On 27 November, the Academy hosted a one-day workshop on ’Conflicts of interest’ as part of its wider workstream on ‘How does society use evidence to judge the risks and benefits of medicines?’.
The event, chaired by Baroness Onora O’Neill CH CBE HonFRS FBA FMedSci, brought together 40 participants from across academia, industry, the media, journals, patient groups, and the wider regulatory and healthcare sectors. The workshop provided an opportunity to:
- Consider what interests impact on the validity (or perception of the validity) of evidence about medicines and decisions about their use.
- Explore how these interests might be identified, communicated, and managed.
- Identify key questions, uncertainties and/or common principles in declaring and managing interests.
Baroness O’Neill opened the meeting by offering initial perspectives on how to identify and declare interests, how to determine when an interest poses a conflict, and potential strategies for their management. The day also included three panel discussions to further explore what actions should be taken in order to manage interests when funding research, generating and analysing data, disseminating findings, and using evidence to inform policy and practice.
Many relevant issues emerged during the course of the workshop and gave rise to lively and wide-ranging discussions. A full report of the workshop will be published in early 2016, and will inform the deliberations of the Academy's ‘How does society use evidence to judge the risks and benefits of medicines?’ Oversight Group.
For further information on the 'Conflicts of interest' workshop, please visit our policy project page.
For further information on the ‘How does society use evidence to judge the risks and benefits of medicines?’ workstream, please visit our policy project page.
To submit evidence to this project, please visit our call for evidence page.